Brought to you by 
Notes offering nets $671.3mm for Exact Sciences
11 Jun 2018
Executive Summary
Exact Sciences Corp. (molecular diagnostics for cancer) netted $671.3mm through the public sale of $690mm aggregate amount, including the overallotment, of its 1% senior notes due 2025. The notes bear interest at 1% and convert to common shares at a rate of 13.2569 shares per $1k principal amount, or $75.43. (The company's stock averaged $53.79 at the time of the offering.)
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Laboratory Testing Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Notes offering nets $671.3mm for Exact Sciences
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice